In this work, we describe the process of cell death induced by a series of new benzo(b)thiophenesulphonamide 1,1-dioxide derivatives (BTS) that have been selected as candidate antineoplastic drugs. Human leukaemic CCRF-CEM cells incubated with BTS undergo a typical apoptotic process that includes cell shrinkage, phosphatidylserine translocation to the cell surface, mitochondrial dysfunction, caspase activation, chromatin condensation and internucleosomal DNA degradation. Mitochondrial alterations included dissipation of the mitochondrial membrane potential, oxidation of the phospholipid cardiolipin, release of cytochrome c and uncoupling of the mitochondrial respiratory chain, leading to a decrease of the intracellular ATP pool. Activation of caspase-8, -9 and -3 takes place during BTS-induced apoptosis. Either the addition of the specific caspase-8 inhibitor Z-IETDfmk, or the overexpression of the antiapoptotic protein Bcl-2 significantly prevented BTS-induced apoptosis, suggesting the involvement of both caspase-8-regulated and mitochondria-dependent signalling pathways in this process. BTS induce a significant increase in the production and accumulation of intracellular reactive oxygen species (ROS) that can be observed within minutes after drug addition. Moreover, cytochrome c release, caspase-3 activation and cell death can be completely abrogated by a previous incubation with the antioxidant N-acetyl-cysteine. These results suggest that ROS are essential mediators in BTS-induced apoptosis.
Introduction
A series of benzo(b)thiophenesulphonamide 1,1-dioxide derivatives (BTS), some of them closely related to diarylsulphonylureas (DSU), show in vitro cytotoxic activity on tumour cells. At the beginning of the 1990s, some DSU were described as a group of molecules with interesting antitumoral properties, and a high number of DSU were synthesized and analysed in a program of screening to identify new antitumour drugs (Howbert et al., 1990) . After theoretic structure-activity COMFA studies carried out on the basis of those data, we initially designed, synthesized and tested in in vitro antitumour assays several analogues and derivatives of DSU. Based on the results obtained in these experiments, we synthesized a second generation of molecules. Among them, we identified a group of BTS that showed cytotoxic antitumoral activity at doses lower than or similar to those observed with the best DSU, and whose toxicity was predicted to be lower (Martinez-Merino et al., 2000) .
Owing to the potential clinical interest of BTS, we decided to focus on the characterization of the process of cell death triggered by them. These studies look particularly interesting since the mechanism by which DSU induce tumour cell death remains unknown and seems to be different from those described for other antitumour drugs (Sosinski et al., 1993) . It is known that many anticancer drugs are able to induce apoptosis on tumour cells (Cotter et al., 1992; Green et al., 1994; Martin et al., 1994; Oridate et al., 1995) , and alterations in mitochondrial physiology have been described in many of these apoptotic responses Reed and Kroemer, 2000) . These alterations include the collapse of the inner mitochondrial membrane potential (DCm) (Zamzami et al., 1995) and the permeabilization of the outer mitochondrial membrane (OMM) . As a result of OMM permeabilization, proapoptotic factors such as cytochrome c, AIF and Smac/Diablo that are normally stored in the intermembrane space can be released to the cytoplasm (reviewed in Green and Reed, 1998) . Once there, these proteins are able to trigger further events of the so-called mitochondria-dependent apoptotic pathway. Caspases are a family of cysteine proteases that can be activated by proteolysis and play a key role during apoptosis. Some chemotherapeutic agents such as cisplatin, etoposide, paclitaxel and doxorubicine induce the activation of caspase-8 in a Fas-dependent or independent fashion (Kim et al., 2001) . Activation of caspase-8 can lead to the cleavage of the effector procaspase-3 and thus trigger further apoptotic events without involving mitochondrial alterations. However, caspase-8 may also help to amplify mitochondriadependent apoptosis through a feedforward loop in which initial mitochondrial damage causes caspase-3 activation. This caspase activates caspase-8, which activates proapoptotic molecules like Bid that cause further mitochondrial release of cytochrome c and caspase-3 activation (Tang et al., 2000) .
Accumulation of reactive oxygen species (ROS) has been proposed to be an early essential event in apoptotic responses induced by some antitumour drugs and other factors such as tumour necrosis factor a (Buttke and Sandstrom, 1995; Zamzami et al., 1995) . Moreover, overexpression of Mn-superoxide dismutase has been proved to completely suppress this process in some apoptotic models (Keller et al., 1998) . N-(4-hydroxyphenyl)retinamide (4-HPR), currently used in cancer therapy trials, induces apoptosis in cervical carcinoma cells by enhancing ROS generation by some components of the mitochondrial respiratory chain (MRC) (Suzuki et al., 1999) . Excessive ROS accumulation exerts a number of effects on mitochondrial physiology that can lead to the activation of mitochondria-dependent apoptotic pathways. The mitochondria-specific phospholipid cardiolipin (CL) might be one important target of ROS in the mitochondria. CL is located exclusively in the inner membrane of mitochondria (IMM), and it is associated with some components of the permeability transition pore, which has been proposed to mediate permeability changes in the mitochondrial membranes during apoptosis, and with cytochrome c (Skulachev, 1998) . ROS accumulation results in the peroxidation of CL and the dissociation of cytochrome c from the IMM (Nomura et al., 2001) . Moreover, it has been shown that Trolox, an inhibitor of CL peroxidation, suppresses the apoptosis induced by the NO donor glycerol trinitrate in Jurkat cells (Umansky et al., 2001) . In the present study, we describe in detail the apoptotic process induced by BTS in human leukaemic CCRF-CEM (CEM) cells. Our results indicate that BTS-induced apoptosis is mediated by the overgeneration of ROS and that mitochondrial dysfunction and activation of caspase-8 are important events involved in this process.
Results

BTS trigger apoptosis on CEM cells
The structure of the six BTS used in this work is shown in Figure 1 . All these compounds were able to kill tumour cells in in vitro assays with GI 50 values (drug concentration that inhibits 50% of tumour cell growth) ranging from 5 to 50 mm, except the inactive compound D, which is a reduced derivative of C and was used as a negative control (Martinez-Merino et al., 2000) .
To investigate the process of cell death induced by BTS in the CEM cells, we cultured cell samples for 3-24 h in the presence of BTS and analysed their lightscattering profile (LSP) by flow cytometry (Table 1, Figure 2a ). Cells incubated with active BTS showed a progressive loss of their normal structure, as revealed by the alteration of their LSP. A cell subpopulation showing typical apoptotic features, that is, small size and increased cellular granularity (Huschtscha et al., 1996) , appeared and its size increased progressively. Less than 5% of the cells maintained their original cell structure and LSP 24 h after BTS addition. The next parameters studied by flow cytometry were analysed in populations with normal LSP by gating the cells in a forward light scatter/side light scatter (FSC/SSC) plot. Plasma membrane integrity was analysed by supravital PI staining (Zamai et al., 2001) . As shown in Table 1 and Figure 2b , a progressive increase in the percentage of PI-positive cells could be observed, revealing that typical apoptotic membrane alterations precede the inner disorganization of the cell. In parallel, other cell samples were fixed in ethanol before PI staining to quantify the percentage of cells with normal LSP that have started to lose DNA and show a sub-G 1 DNA content. When the whole cell population was considered, more than 95% of the cells showed a sub-G 1 DNA content 24 h after BTS addition (data not shown). When only cells with normal LSP were analysed, some differences in the kinetics could be observed between cells treated with different BTS (Table 1 and Figure 2c and d). Compounds A and C induced a progressive increase in the percentage of sub-G 1 cells with the time of incubation to reach levels of 60-70% 24 h after the addition of the drug. In contrast, the other active BTS induced a moderate increase in that population, indicating that the lapse of time between the loss of DNA and the loss of normal LSP is shorter in that case. Compound C was the most active of the tested BTS, while the negative control D lacked any cytotoxic activity.
Ultrastructural analysis of BTS-treated CEM cells by conventional electron microscopy revealed typical apoptotic nuclear morphology including chromatin condensation and fragmentation of the nucleus in small (Figure 2e ). Initially, the cytoplasm maintained a normal morphology and was surrounded by an apparently intact plasma membrane. To study genomic damage induced by BTS, we isolated DNA from cell samples incubated during different periods of time with compound C and analysed them by gel electrophoresis. After 12 h of incubation, the DNA appeared degraded forming the characteristic 200 bp ladder typically observed in apoptotic cells (Figure 2f) . A kinetic summary of these data is shown in Table 2 . The translocation of the phospholipid phosphatidylserine (PS) to the outer leaflet of the plasma membrane is considered as an early marker of apoptosis. We stained cell samples with annexin-V-FITC and determined the percentage of PS-positive cells by fluorescence microscopy. A progressive increase of positive cells could be observed, reaching a maximum after 12 h of exposure to the drug (data not shown; Table 2 ).
BTS induce changes in cell cycle distribution of CEM cells
We analysed the cell cycle distribution in CEM populations treated with BTS by PI staining and flow cytometry ( Figure 2c , Table 1 ). We found that BTS initially induced a progressive decrease in the population with a G 1 DNA content and a simultaneous accumulation of cells in the G 2 /M area. This suggests that BTS are able to induce cell cycle arrest at the G 2 /M checkpoint, thus preventing cells to complete division and acquire again a G 1 DNA content. After that, an increase in the S area was observed, that could be explained by assuming that cells stacking in the G 2 /M checkpoint started to enter apoptosis, losing DNA and appearing in the intermediate area between G 1 and G 2 . The fact that the G 1 peak does not completely disappear indicates that there is also the activation of some checkpoint response(s) inducing cell cycle arrest at this phase.
BTS effect is mediated by ROS production
ROS excessive accumulation has been reported to play an essential role during tumour cell apoptosis induced by several drugs (Boutonnat et al., 2000; Costantini et al., 2000) . As shown in Figure 3a , active BTS induced a clear, near twofold increase in the rate of ROS generation. This effect was similar to the one observed with the positive control 4-HPR, which has been previously reported to induce ROS overgeneration on Characterization of BTS-induced apoptosis MM Alonso et al cervical carcinoma C33A cells (Oridate et al., 1997b) . To investigate if the observed accumulation of ROS was really essential for the cytotoxic effect of BTS, we performed in vitro cytotoxicity assays with BTS in the presence or absence of the antioxidant NAC, which was added to the culture medium 2 h before. As depicted in Figure 3b , all compounds except the negative control D exerted a clear cytotoxic effect that was completely abrogated by the previous addition of NAC. These data indicate that ROS are essential mediators in BTSinduced apoptosis.
BTS induce alterations in mitochondrial physiology
Mitochondria have been reported to play a pivotal role in many apoptotic processes. To characterize the effect of BTS on mitochondrial physiology, we first analysed the DCm in cells treated with BTS B and C by flow cytometry using the fluorescent probe rhodamine-123 (RH-123). Not surprisingly, we found that these compounds induce the collapse of DCm (data not shown; Table 2 ), as it has been shown for other apoptosis inducers (Zamzami and Kroemer, 2001) . Taking into account the crucial role that ROS play in BTS-induced apoptosis, it seemed interesting to analyse the levels of peroxidation of the mitochondria-specific phospholipid CL. Nonyl-acridine orange (NAO) staining and flow cytometry analysis revealed a clear and progressive reduction in the levels of nonperoxidated CL in CEM cells incubated in the presence of BTS (Figure 4a ), reflecting the progressive oxidation of this phospholipid by ROS. The release of cytochrome c to the cytoplasm as a consequence of alterations in the OMM permeability has been reported in different apoptotic processes. BTS induced the mitochondrial release of cytochrome c to the cytoplasm, as revealed by Western blot analysis (Figure 4b ). This effect was inhibited by the previous addition of NAC, indicating that BTS-induced ROS generation is a previous event required to trigger cytochrome c release from the mitochondria.
In some models of apoptosis, a reduction in the cell ATP pool as a consequence of the uncoupling of the MRC has been demonstrated. We found that BTS B and C are able to induce a progressive decrease in the ATP pools of CEM cells (Figure 4c ), indicating that the uncoupling of the MRC takes place as a part of the apoptotic process. The effect of compound C was faster and more pronounced than the one observed with compound B, correlating with the kinetics of the morphological and membrane alterations previously observed by PI staining (Figure 2 ).
Expression of Bcl-2 protein family members Bcl-2, Bcl-xl, Bax and Bak is not altered in BTS-treated cells
The members of the Bcl-2 protein family regulate changes in OMM permeability during apoptosis, and the expression levels of some of them have been observed to be altered in several apoptotic processes 5 cells/well) and incubated with or without BTS (100 mm) and 4-HPR (10 mm) in the presence of DCFH-DA (10 mm/ml). Intracellular ROS levels were measured every 2 min during 6 h as described in Materials and methods. These data were used to generate a trend line, whose slope was taken as an estimation of the rate of ROS generation (Fl.U ¼ fluorescence units). The results are presented as the mean7s.d. of the data obtained in two independent experiments (sextuplicate wells). (b) Cells were incubated with the six BTS in the presence or absence of NAC (30 mm) for 24 h, and then cell survival was evaluated by an XTT-based colorimetric assay. The addition of NAC completely abrogates the cytotoxic effect of all BTS (Susin et al., 1998) . As can be seen in the Western blots shown in Figure 5a , neither antiapoptotic (Bcl-2, Bcl-xl) nor proapoptotic (Bax, Bak) tested proteins suffer any change in their expression as a consequence of the incubation with BTS C; similar results were obtained with compound B (data not shown). Preincubation with NAC did not significantly modify the expression of any of these proteins.
BTS-induced cell death is partially inhibited by Bcl-2 overexpression
To determine the role of the antiapoptotic protein Bcl-2 in the process of cell death induced by BTS, we used CEM-C7H2-10E1 cells stably transfected with a bcl-2 cDNA-containing vector that overexpresses bcl-2 (Hartmann et al., 1999). We treated in parallel 10E1 and parental CEM cells with BTS (100 and 10 mm) for 24 h, and we measured the final cell viability by a standard colorimetric MTT cytotoxicity assay. Interestingly, overexpression of Bcl-2 exerts around 50% inhibition of the cytotoxic effect of BTS (100 mm) (Figure 5b ). These results suggest that both mitochondria-dependent and -independent cell death pathways might be activated by BTS.
Caspase-8, -9 and -3 become activated during BTSinduced apoptosis
Capase-8, -9 and -3 are critically involved in many processes of drug-induced apoptosis (Ferreira et al., 2000; Seki et al., 2000) . We measured the activity of these proteases in CEM cells treated with BTS for different periods of time using a fluorimetric assay. As shown in Figure 6a , a fourfold increase of caspase-8 activity was observed after 4 h of BTS treatment. Caspase-9 and -3 were also activated 4 h after incubation, but the peak of activity of these proteases took place later. Cleavage of procaspase-3 to generate the active enzyme was also demonstrated by Western blot (Figure 5a ). Consistent with previous results, caspase-3 activation could be completely abrogated by preincubation with NAC.
Caspase-8 inhibitor (Z-IETD-fmk) partially prevents the cytotoxic effect of BTS
Addition of caspase-3 (Z-DEVD-fmk) and -9 (Z-LEHD-fmk) inhibitors to BTS-treated CEM cells substantially prevented the development of apoptotic morphology (data not shown) but not cell death (Figure 6b ). In contrast, addition of caspase-8 inhibitor (Z-IETD-fmk) partially blocked the effect of compounds B and C and therefore more than 50% of the cells were still alive after 24 h of treatment (Figure 6b ). These data further support the idea that caspase-9 and -3 must be downstream of caspase-8 during BTS-induced apoptosis, and that the activation of caspase-8 also triggers caspase-3-and -9-independent events that culminate with cell death.
Discussion
Our results indicate that BTS induce a typical process of apoptosis in CEM cells that includes cell shrinkage, PS translocation to the cell surface, mitochondrial dysfunction, caspase activation, chromatin condensation and internucleosomal DNA degradation. CEM cells start to accumulate ROS within minutes after BTS addition (Table 2) , and these molecules are essential mediators required for the induction of cytochrome c mitochondrial release, caspase-3 activation and cell death, as revealed by the fact that these three events could be prevented by preincubation with the antioxidant NAC (Figures 3-5) . In this sense, BTS are similar to other antitumour compounds that have been shown to induce apoptosis through a mechanism mediated by ROS (Oridate et al., 1997b; Koren et al., 2000) . Additional investigation is required to find out the precise origin of BTS-induced ROS. We have previously reported that BTS are able to inhibit an NADH oxidase of unknown physiologic function that is located in the plasma membrane of CEM and other tumour cells (Alonso et al., 2001) . The putative implication of this enzyme and/or other ROS-generating systems of the cell such as the MRC in BTS-induced ROS generation are interesting issues to be analysed in future experiments. The results obtained in this work and their kinetic analysis allow us to formulate a tentative model to describe BTS-induced cell death (Figure 7) . After ROS accumulation, early events in BTS-induced apoptosis include a series of mitochondrial physiology alterations that could be due to the oxidative activity of ROS on CL. Our data suggest that ROS cause IMM structural damage. DCm dissipation, uncoupling of the MRC and a decrease of ATP intracellular concentration. These phenomena can lead to the complete collapse of the energetic cell metabolism and eventually to cell death, even if BTS-activated apoptotic pathways have been artificially blocked, as discussed later. On the other hand, mitochondrial cytochrome c release caused by OMM permeabilization most probably induces the activation of caspase-9 and subsequently of the effector caspase-3. Caspase-8 is also activated in cells incubated with BTS; this caspase can directly cleave procaspase-3 leading to apoptosis through a mitochondrial-independent pathway. Caspase-8 participates in cell death signalling during apoptosis induced by many different antitumour drugs, and it can be activated through membrane death receptor-dependent or -independent pathways. In our model, caspase-8 activation should be a consequence of ROS activity, but the intermediate steps and molecules that play a role in this process remain to be identified. As discussed in the Introduction, caspase-8 can also be activated by caspase-3, participating in mitochondria-dependent cell death signalling amplification. In our case, it seems improbable that this was the main role played by caspase-8 since (i) the peak of caspase-8 activity precedes that of caspase-3 activity and (ii) caspase-8 inhibition results in significantly reduced cell death, while caspase-3 inhibition does not.
The last result suggests that caspase-8 is upstream to caspase-3 in BTS-induced apoptosis, and that it is able to trigger cell death by caspase-3-independent mechanisms. Thus, according to our model, BTS induce the activation of two independent apoptotic pathways, one mediated by mitochondria dysfunction and the other controlled by caspase-8. These two pathways can interact, and both of them can be blocked by the antiapoptotic regulator Bcl-2. Consistent with this, Bcl-2 overexpression significantly inhibited cell death induced by BTS. However, a percentage of Bcl-2-overexpressing cells still died after BTS addition, perhaps because they cannot recover from the collapse of the energetic metabolism owing to mitochodrial damage caused by ROS.
Many antitumour agents have been reported to alter cell cycle distribution or to be specific for a concrete phase of the cell cycle (Huschtscha et al., 1996) . It has been extensively described that oxidative stress induces the activation of a number of intracellular signal pathways that can result in cell cycle arrest or apoptosis, and at least some of them are probably triggered by ROS-mediated DNA damage. The activation of the regulatory protein p53 is a key step in most of these processes (Li et al., 1999) . The perturbations observed in the cell cycle distribution of CEM cells incubated with BTS (Figure 2c and d, Table 1 ) suggest that some checkpoint response pathways have been activated in these cells. These results indicate that the cell cycle has been blocked particularly at the G 2 /M phases, which could be owing to p53 activation (Taylor and Stark, 2001) In any case, further experiments are required to clarify the cell cycle regulatory mechanisms activated by BTS.
Materials and methods
Cell culture
The acute leukaemic T-lymphocyte cell line CCRF-CEM (ATCC, Manassas, VA, USA) and the CCRF-CEM-C7H2-10E1 cell line (kindly provided by Dr Kofler) (Hartmann et al., 1999) that is stably transfected with bcl-2 c-DNA were grown in RPMI 1640 medium (Gibco, Grand Island, NY, USA), supplemented with 10% foetal calf serum and 0.1 mg/ml gentamicin.
Chemicals
BTS used in this work were synthesized as previously described by Martinez-Merino et al. (2000) . BTS and the synthetic retinoid 4-HPR (Sigma, St Louis, MO, USA) were initially dissolved in DMSO at 0.1 m. All BTS were normally used at a 100 mm final concentration, while 4-HPR was used at 10 mm. The antioxidant NAC (Sigma, St Louis, MO, USA) was dissolved in culture medium and used at a 30 mm concentration.
Assesment of apoptosis by fluorescence microscopy, flow cytometry and electron microscopy PS exposure on the outer leaflet of the plasma membrane was detected using the annexin-V: FITC Apoalert detection kit by Clontech (Palo Alto, CA, USA) according to the manufacturer's directions. In brief, after drug treatment (2, 4, 6, 8, 10 and 12 h) 5 Â 10 5 cells were pelleted and washed in PBS. Cells were then stained with the fluorescence probes annexin-V: FITC and PI (to discard the necrotic cells) and evaluated under a fluorescence microscopy.
For flow cytometry analysis, cells were cultured in the presence or absence of BTS and collected at times ranging from 3 to 24 h. Integrity of plasma membranes was evaluated by supravital staining of nonfixed cells with PI (Molecular Probes, Eugene, OR, USA) (5 mm) and flow cytometric analysis. Independent samples from the same cultures were fixed in 70% ethanol at 41C for 20 min and the DNA content of individual cells was estimated by staining with PI (50 mm) and flow cytometry (Phillips et al., 1997) . For cell cycle analysis, cells were analysed by flow cytometry using the FL2 DDM mode. Single cells were gated in a FL2 Area/FL2 width plot, and G 1 /G 0 , S and G2/M regions were determined in an FL2 Area histogram as described by Zamai et al. (2001) .
For transmission electron microscopy (TEM) analysis, CEM cells were cultured in the presence or absence of the compound B for up to 24 h. Cell samples were then collected by centrifugation and prepared for conventional TEM analysis (Bozolla and Russell, 1992) .
Assay of generation of ROS
The rate of net intracellular generation of ROS was measured by using the oxidation-sensitive fluorescent dye 5,6-carboxy-2 0 ,7 0 -dichlorofluorescein diacetate (DCFH-DA) (Molecular Probes, Eugene, OR, USA), following the method described by Oridate et al. (1997a) using a Fluoroskan II fluorimeter (Labsystems, Helsinki, Finland) . Results were expressed as the mean slope of ROS generation from sextuplicate wells for each sample or control (in fluorescence units per minute).
Cytotoxicity in vitro assay
For cytotoxicity evaluation, cells were first incubated in roundbottomed 96-well plates in the presence of BTS, and cell survival was evaluated 24 h later by an XTT-based colorimetric assay using a commercial kit (Roche, Indianapolis, IN, USA), as described by Scudiero et al. (1988) or by a similar MTT-based assay (Mossmann, 1983) . When indicated, cells were preincubated with NAC 2 h before BTS addition; caspase-8, -9 and -3 inhibitors (Z-IETD-fmk, Z-LEHD-fmk and Z-DEVD-fmk) were added (50 mm) at the same time as BTS.
Evaluation of mitochondrial damage
Changes in mitochondrial transmembrane potential were measured using the fluorescent probe RH-123 (Molecular Probes, Eugene, OR, USA) as described by Shapiro (2000) . CL oxidation was assayed using the fluorescent probe NAO (Molecular Probes, Eugene, OR, USA) following the method of Umansky et al. (2000) . The presence of cytochrome c in cytoplasmic and mitochondrial subcellular fractions was analysed using the ApoAlert Cell Fractiontion kit (Clontech, Palo Alto, CA, USA) following the manufacturer's directions.
Quantification of intracellular ATP levels
After treatment with the indicated compounds for 2-24 h, cells were collected and lysates were prepared using the Cell Culture Lysis Reagent (CCLR) (Promega, Madison, WI, USA). ATP was quantified in aliquots of 20 mg of protein using a Luciferin and Luciferase ATP determination kit (Molecular Probes, Eugene, OR, USA). The reagents were prepared according to the manufacturer's recommendations, light intensity was quantified using a luminometer (Lumat LB 9501, Fa. Berthold, Wildbad) and ATP concentrations were calculated according to the manufacturer's instructions.
DNA extraction and gel electrophoresis
For assessment of DNA damage, cells were cultured in the presence or in the absence of BTS (100 mm) for the indicated periods of time. DNA was isolated from cell pellets following standard phenol/chloroform/isoamylalcohol extraction procedures. Purified DNA was divided in 20 mg -aliquots and analysed by electrophoresis on 1% agarose gel.
Protein expression analysis by Western blot
For Western blot analysis, cells were cultured in the presence or absence of NAC for 2 h. Then compound B or C was added and cells were incubated for the period of time indicated and collected by centrifugation. For protein extraction, cell pellets were resuspended in a lysis buffer (SDS 1%, sodic orthovanadate 1 mm and Tris-HCl 10 mm, pH 7.4) at 2 Â 10 6 cells per 100 ml. Samples were then centrifuged and supernatants were boiled for 5 min and passed through a needle of 20 0 gauge. A volume of 20 mg of protein from each sample was subjected to SDS-PAGE electrophoresis and transferred to nitrocellulose membranes. Membranes were probed with antibodies to detect Bcl-2, a-actin (Roche, Indianapolis, IN, USA), Bcl-xl, Bak (R&D Systems, Minneapolis, MN, USA), Bax and Caspase-3 (St Cruz, California, CA, USA) using standard Immunoblotting techniques.
Measurement of caspase activity
Activity of caspase-8, -9 and -3 was measured using a Caspase profiling plate (Clontech, Palo Alto, CA, USA) following the manufacturer's directions. Cells were cultured with or without BTS and NAC as described before.
